---
title: "Mavens Biotech Ltd (590083) — Share Price, Financials & Analysis"
symbol: "590083"
company: "Mavens Biotech Ltd"
canonical: "https://tapetide.com/stocks/590083"
isin: "INE856C01047"
bse_code: "590083"
sector: "Healthcare"
industry: "Pharmaceuticals & Biotechnology"
generated_at: "2026-09-13T18:59:04.286Z"
---

# Mavens Biotech Ltd (590083)

Canonical page: https://tapetide.com/stocks/590083

## Company

- **BSE Code:** 590083
- **ISIN:** INE856C01047
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals & Biotechnology
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2008-05-06
- **Face Value:** ₹1
- **F&O Eligible:** No
- **Website:** mavensbiotech.com

## About

Mavens Biotech Ltd. engages in agricultural biotechnology business in India. The company propagates plants by tissue culture and introduces new breeds of plant material.

## Latest Price

## Key Insights

### Strengths

- Company is almost debt free.
- Stock is trading at 0.91 times its book value

### Weaknesses

- Company has low interest coverage ratio.
- Company has a low return on equity of -11.1% over last 3 years.
- Contingent liabilities of Rs.3.56 Cr.

## Growth Rates

| Metric | 1Y |
| --- | --- |
| net income growth | 82% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2014 | Jun 2014 | Sep 2014 | Dec 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 7.2 | 0.25 | 0.18 | 0.23 | 0.4 | 0.2 | 0.21 | 0.22 | 0.19 | 0.21 | 0.35 | 0.2 |
| Expenses | 7.41 | 0.19 | 0.13 | 0.18 | 0.24 | 0.13 | 0.15 | 0.13 | 0.14 | 0.17 | 0.32 | 0.17 |
| Operating Profit | -0.21 | 0.06 | 0.05 | 0.05 | 0.16 | 0.07 | 0.06 | 0.09 | 0.05 | 0.04 | 0.03 | 0.03 |
| OPM % | -2.92 | 24 | 27.78 | 21.74 | 40 | 35 | 28.57 | 40.91 | 26.32 | 19.05 | 8.57 | 15 |
| Other Income | 0.03 | 0.03 | 0.02 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0.05 | 0.04 | 0.04 | 0.04 | 0.15 | 0.04 | 0.04 | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 |
| Profit before tax | -0.23 | 0.05 | 0.03 | 0.04 | 0.01 | 0.03 | 0.02 | 0.05 | 0.01 | 0.01 | 0 | 0 |
| Tax % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | — |
| Net Profit | -0.24 | 0.04 | 0.03 | 0.04 | 0.01 | 0.04 | 0.02 | 0.05 | 0.01 | 0.01 | 0.01 | 0.01 |
| EPS in Rs | -0.02 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 55.99 | 45.56 | 45.83 | 0.82 | 1.06 | 0.83 | 0.96 | 0.18 | 0 | 0 |
| Expenses | 54.78 | 44.49 | 44.89 | 0.64 | 0.74 | 0.56 | 0.83 | 0.43 | 2.22 | 0.39 |
| Operating Profit | 1.21 | 1.07 | 0.94 | 0.18 | 0.32 | 0.27 | 0.13 | -0.25 | -2.22 | -0.39 |
| OPM % | 2.16 | 2.35 | 2.05 | 21.95 | 30.19 | 32.53 | 13.54 | -138.89 | — | — |
| Other Income | 0.13 | 0.11 | 0.09 | 0.11 | 0.08 | 0 | 1.22 | -1.87 | -1.22 | -0.44 |
| Interest | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0.41 | 0.37 | 0.28 | 0.22 | 0.28 | 0.15 | 0.1 | 0.07 | 0.02 | 0.01 |
| Profit before tax | 0.92 | 0.81 | 0.75 | 0.07 | 0.12 | 0.12 | 1.25 | -2.19 | -3.46 | -0.84 |
| Tax % | 0 | 13.58 | 4 | 14.29 | 0 | 33.33 | 10.4 | -0.46 | -1.73 | 0 |
| Net Profit | 0.92 | 0.7 | 0.71 | 0.07 | 0.13 | 0.08 | 1.12 | -2.18 | -3.4 | -0.84 |
| EPS in Rs | 0.08 | 0.06 | 0.06 | 0.01 | 0.01 | 0.01 | 0.1 | -0.2 | -0.31 | -0.08 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 10.99 | 10.99 | 10.99 | 10.99 | 10.99 | 10.99 | 10.99 | 10.99 | 10.99 | 10.99 |
| Reserves | 6.65 | 7.35 | 8.05 | 8.12 | 8.15 | 8.23 | 1.1 | -1.07 | -4.47 | -5.31 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0.41 | 0.45 | 0.39 | 0.3 | 0.31 | 0.34 | 0.32 | 0.19 | 1.02 | 0.29 |
| Total Liabilities | 18.05 | 18.79 | 19.43 | 19.41 | 19.45 | 19.56 | 12.41 | 10.11 | 7.54 | 5.97 |
| Fixed Assets | 5.29 | 5.24 | 4.96 | 4.74 | 4.37 | 4.22 | 4.12 | 3.95 | 3.75 | 3.74 |
| CWIP | 1.32 | 1.44 | 1.44 | 1.44 | 1.44 | 1.44 | 0 | 0 | 0 | 0 |
| Investments | 0.25 | 0.42 | 0.42 | 0.42 | 0.42 | 0.42 | 1.67 | 1.6 | 1.6 | 1.6 |
| Other Assets | 11.19 | 11.69 | 12.61 | 12.81 | 13.22 | 13.48 | 6.62 | 4.56 | 2.19 | 0.63 |
| Total Assets | 18.05 | 18.79 | 19.43 | 19.41 | 19.45 | 19.56 | 12.41 | 10.11 | 7.54 | 5.97 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 0.74 | 0.42 | -0.07 | -0.01 | -0.11 | 0.04 | -0.1 | -0.2 | 0 | -0.04 |
| Cash from Investing Activity | -0.65 | -0.51 | 0.09 | 0.05 | 0.08 | -0.01 | -0.03 | 0.09 | 0.02 | 0.02 |
| Cash from Financing Activity | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 0.09 | -0.09 | 0.02 | 0.04 | -0.03 | 0.04 | -0.13 | -0.11 | 0.02 | -0.02 |
| Free Cash Flow | -0.04 | -0.03 | -0.07 | -0.01 | -0.11 | 0.03 | -0.1 | -0.16 | 0 | -0.04 |
| CFO/OP | 68 | 45 | -3 | -6 | -19 | 15 | -77 | 76 | 0 | 10 |

### Ratios

| Item | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 23.08 | 32.53 | 35.36 | 2029.76 | 137.74 | 83.55 | 235.73 | 1318.06 | — | — |
| Inventory Days | 21.38 | 25.65 | 24.45 | — | — | — | 542.57 | 1460 | 0 | — |
| Days Payable | 1.22 | 1.59 | 0.99 | — | — | — | 0 | 0 | — | — |
| Cash Conversion Cycle | 43.23 | 56.59 | 58.82 | 2029.76 | 137.74 | 83.55 | 778.3 | 2778.06 | — | — |
| Working Capital Days | 41.27 | 53.68 | 56.07 | 3191.52 | 27.55 | -65.96 | 562.71 | 3183.61 | — | — |
| ROCE % | 5.41 | 4.5 | 4.01 | 0.37 | 0.63 | 0.63 | 7.98 | -2.45 | -27.01 | -6.23 |

## Shareholding Pattern

### annual

| Category | Dec 2016 |
| --- | --- |
| Promoters | 32.04% |
| Public | 67.96% |
| No. of Shareholders | 12139 |

### Quarterly

| Category | Jun 2016 | Sep 2016 | Dec 2016 |
| --- | --- | --- | --- |
| Promoters | 32.04% | 32.04% | 32.04% |
| Public | 67.96% | 67.96% | 67.96% |
| No. of Shareholders | 12433 | 12373 | 12139 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 1 / 6 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 1.9 | Sell |
| EMA (10) | 1.91 | Sell |
| SMA (20) | 1.96 | Sell |
| EMA (20) | 1.95 | Sell |
| SMA (50) | 2.07 | Sell |
| EMA (50) | 2.06 | Sell |
| SMA (100) | 2.2 | Sell |
| EMA (100) | 2.23 | Sell |
| SMA (200) | 2.45 | Sell |
| EMA (200) | 3.06 | Sell |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 38.37 | Neutral |
| MACD (12,26,9) | -0.06 | Sell |
| Stochastic (14,3,3) | 44.46 | Neutral |
| ADX (14) | 35.1 | Buy |
| Williams %R (14) | -52.83 | Neutral |
| ATR (14) | 0.15 | High Volatility |
| ROC (12) | -9.22 | Sell |
| Stoch RSI (14) | 34.83 | Neutral |
| UO (7,14,28) | 67.81 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 31 Jan - Newspaper Publication of Unaudited Financial Results for the quarter and nine months ended 31st Dec 2025 | [Announcement under Regulation 30 (LODR)-Newspaper Publication 31 Jan - Newspaper Publication of Unaudited Financial Results for the quarter and nine months ended 31st Dec 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/99ba7d92-358d-4848-afd8-154785cbcb25.pdf) |
| 29 Jan - Mr. Devesh Vasavada ceases as Independent Director and audit committee chair effective COB 4 Feb 2026. | [Announcement under Regulation 30 (LODR)-Change in Directorate 29 Jan - Mr. Devesh Vasavada ceases as Independent Director and audit committee chair effective COB 4 Feb 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/68e8cd95-21c4-4446-8207-8fb87ac27c1b.pdf) |
| 13 Feb - Ms Daya Bhalia ceased as Executive Director effective 13 Feb 2026; will remain Company Secretary & Compliance Officer. | [Announcement under Regulation 30 (LODR)-Change in Directorate 13 Feb - Ms Daya Bhalia ceased as Executive Director effective 13 Feb 2026; will remain Company Secretary & Compliance Officer.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8837bafc-3714-4de6-a177-65787fc91ea7.pdf) |
| — | [Shareholder Meeting / Postal Ballot-Scrutinizer"s Report 10 Feb](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1106e871-768f-46be-81ec-0f5dca27b1a0.pdf) |
| — | [Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot 10 Feb](https://www.bseindia.com/xml-data/corpfiling/AttachHis/024cd6e7-a325-4633-b0dc-119b1ce6817f.pdf) |
| — | [Standalone Financial Results, Limited Review Report for December 31, 2016 10 Feb 2017](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9D548B88_FC17_4199_BFE5_EDC16205197C_161553.pdf) |
| — | [Standalone Financial Results, Limited Review Report for December 31, 2016 10 Feb 2017](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2017/2/9D548B88_FC17_4199_BFE5_EDC16205197C_161553.pdf) |
| — | [Board Meeting Intimation for Results & Closure of Trading Window 30 Jan 2017](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4250FB17_D505_4397_941D_FE1F751D9688_183330.pdf) |
| — | [Board Meeting Intimation for Results & Closure of Trading Window 30 Jan 2017](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2017/1/4250FB17_D505_4397_941D_FE1F751D9688_183330.pdf) |
| — | [Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016 13 Jan 2017](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=B1B09985_D853_404E_BBB5_6206B40290BC_113519.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1b208ea5-1e4f-45e2-ada5-e6f3746817d2.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1777a86a-12d2-4726-8660-95b430dad308.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2c373aaa-a736-4905-859f-83b7503232cf.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/512393/76638512393.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/512393/71925512393.pdf) |
| from bse | [Financial Year 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/512393/66714512393.pdf) |
| from bse | [Financial Year 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/512393/5123930319.pdf) |
| from bse | [Financial Year 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/512393/5123930318.pdf) |
| from bse | [Financial Year 2017 from bse](https://www.bseindia.com/bseplus/AnnualReport/512393/5123930317.pdf) |
| from bse | [Annual Report 2016 from bse](https://www.bseindia.com/bseplus/AnnualReport/590083/5900830316.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:59:04.286Z.